ATE92961T1 - Dns-sequenz. - Google Patents

Dns-sequenz.

Info

Publication number
ATE92961T1
ATE92961T1 AT86902345T AT86902345T ATE92961T1 AT E92961 T1 ATE92961 T1 AT E92961T1 AT 86902345 T AT86902345 T AT 86902345T AT 86902345 T AT86902345 T AT 86902345T AT E92961 T1 ATE92961 T1 AT E92961T1
Authority
AT
Austria
Prior art keywords
dna
dna sequence
dna fragment
desired polypeptide
coding
Prior art date
Application number
AT86902345T
Other languages
English (en)
Inventor
Henrik Dalbo Ge Andersen
Hans H M Dahl
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE92961T1 publication Critical patent/ATE92961T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Diabetes (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT86902345T 1985-04-03 1986-04-03 Dns-sequenz. ATE92961T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK151585A DK151585D0 (da) 1985-04-03 1985-04-03 Dna-sekvens
PCT/DK1986/000029 WO1986005804A1 (en) 1985-04-03 1986-04-03 A dna sequence
EP86902345A EP0218651B1 (de) 1985-04-03 1986-04-03 Dns-sequenz

Publications (1)

Publication Number Publication Date
ATE92961T1 true ATE92961T1 (de) 1993-08-15

Family

ID=8105641

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86902345T ATE92961T1 (de) 1985-04-03 1986-04-03 Dns-sequenz.

Country Status (7)

Country Link
EP (1) EP0218651B1 (de)
JP (1) JP2612264B2 (de)
AT (1) ATE92961T1 (de)
AU (1) AU5695086A (de)
DE (1) DE3688870T2 (de)
DK (2) DK151585D0 (de)
WO (1) WO1986005804A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3783305T2 (de) * 1986-10-09 1993-05-19 Fujisawa Pharmaceutical Co Expressionsvektor fuer menschlichen insulinaehnlichen wachstumsfaktor-i.
US5340725A (en) * 1986-10-09 1994-08-23 Fujisawa Pharmaceutical Co., Ltd. Expression vector for insulin-like growth factor I and method of production
WO1990005185A1 (fr) * 1988-11-07 1990-05-17 L'universite De L'etat A Liege Hormone de croissance humaine modifiee
US6753165B1 (en) 1999-01-14 2004-06-22 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
US20080076706A1 (en) 1997-07-14 2008-03-27 Bolder Biotechnology, Inc. Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
ATE375363T1 (de) * 1997-07-14 2007-10-15 Bolder Biotechnology Inc Derivate des wachstumshormons und verwandte proteine
US8288126B2 (en) 1999-01-14 2012-10-16 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
CA2447632C (en) 2000-06-16 2011-08-02 Asterion Limited Fusion protein agonist comprising a growth hormone binding portion and an external domain of a growth hormone receptor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0009930B2 (de) * 1978-10-10 1988-08-24 The Board Of Trustees Of The Leland Stanford Junior University Rekombinante DNA, Verfahren zu ihrer Herstellung und Herstellung fremder Proteine durch einzellige Wirte, die sie enthalten
US4342832A (en) * 1979-07-05 1982-08-03 Genentech, Inc. Method of constructing a replicable cloning vehicle having quasi-synthetic genes
CA1200773A (en) * 1980-02-29 1986-02-18 William J. Rutter Expression linkers
JPS5967297A (ja) * 1982-10-08 1984-04-16 Kyowa Hakko Kogyo Co Ltd 新規ベクタ−
DE3247922A1 (de) * 1982-12-24 1984-06-28 Boehringer Ingelheim International GmbH, 6507 Ingelheim Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten
US4755465A (en) * 1983-04-25 1988-07-05 Genentech, Inc. Secretion of correctly processed human growth hormone in E. coli and Pseudomonas
JPS60502136A (ja) * 1983-08-10 1985-12-12 アムジエン　インコーポレイテツド 微生物によるインタ−ル−キン２の形質発現

Also Published As

Publication number Publication date
JP2612264B2 (ja) 1997-05-21
DK580886A (da) 1986-12-03
EP0218651B1 (de) 1993-08-11
JPS62502657A (ja) 1987-10-15
DE3688870D1 (de) 1993-09-16
EP0218651A1 (de) 1987-04-22
DE3688870T2 (de) 1993-12-23
AU5695086A (en) 1986-10-23
WO1986005804A1 (en) 1986-10-09
DK151585D0 (da) 1985-04-03
DK580886D0 (da) 1986-12-03

Similar Documents

Publication Publication Date Title
DE3382760D1 (de) Herstellung von funktionellen menschlichen Urokinasepolypeptiden.
DK161152C (da) Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat
DK120387D0 (da) Hybridinterferoner, deres anvendelse som laegemiddel og mellemprodukter til fremstilling af antistoffer og disses anvendelse samt fremgangsmaade til deres fremstilling
FI862756A0 (fi) Fibroektiner.
ES2077747T3 (es) Derivados de hirudina.
NO834128L (no) Nye derivater av tricykliske aminosyrer, fremgangsmaate til deres fremstilling, midler som inneholder disse, og deres anvendelse, samt nye bicykliske aminosyrer som mellomprodukter og fremgangsmaate til deres fremstilling
DK430486A (da) Fremgangsmaade til udvinding af protein
DE3689620D1 (de) Durch cys-kodon modifizierte dns.
DK151585D0 (da) Dna-sekvens
ES547436A0 (es) Un procedimiento para producir un adn complementario clonadoo su adn modificado que codifica un polipeptido de factor denecrosis de tumores
SE8503228L (sv) Ny beta-urogastron-gen
ES8802585A1 (es) Un procedimiento para la preparacion de un plasmido que codifica isopenicilina n sintetasa
DE58908428D1 (de) Sekretormutante von Escherichia coli.
NO840952L (no) Fremgangsmaate til fremstilling av et humant interferon-gamma-polypeptid, rekombinant plasmid omfattende et dna-fragment som koder for peptidet, og mikroorganisme transfermert med plasmidet
DK38889D0 (da) Onkogen-indkodet polypeptid med vaekstfaktoraktivitet
DK447083A (da) Dna, som koder for humant interferon-gamma, rekombinant-dna indeholdende denne dna, mikroorganisme indeholdende rekombinant-dna'en og fremgangsmaade til fremstilling af humant interferon-gamma-polypeptid
ES547600A0 (es) Procedimiento para preparar proteinas encarioticas, procarioticas o viricas.
FI882238A0 (fi) Foerbaettringar i samband med organiska foereningar
DK130290A (da) Lymfokiner, dna-sekvenser, som koder for disse lymfokiner og farmaceutiske midler indeholdende disse lymfokiner
DE3682105D1 (de) Probe, tracers, immunogene und antikoerper von ethosuximid.
DK405684A (da) Promotor-operator-fragment, plasmid indeholdende fragmentet, mikroorganisme transformeret med plasmidet, fremstilling af plasmidet og detsanvendelse til modificering af en mikroorganisme
DK592986A (da) Fremgangsmaade til ydelsesfremme hos nyttedyr, aminophenylethylaminderivater, samt fremgangsmaade til fremstilling deraf
DE3683178D1 (de) Methode zur herstellung monoklonaler antikoerper gegen plasminogenaktivatorfaktor.
DK107785A (da) Ekspressionsplasmider, der kan anvendes i b.subtilis til fremstillingaf prochymosin, og fremgangsmaade til fremstilling af plasmider
DK454286D0 (da) Fremgangsmaade til stabil ekspression af en fremmed polypeptidkodendesekvens samt hermed transformerede e. coli-celler

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee